Drug Profile
PD 142012
Alternative Names: 6-ChlorotacrineLatest Information Update: 30 Jan 2007
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antidementias; Neuroprotectants; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 25 Aug 1998 No-Development-Reported for Alzheimer's disease (Unknown route)
- 05 Dec 1996 Preclinical development for Alzheimer's disease (Unknown route)